These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2955118)

  • 1. Synthesis and evaluation of non-catechol D-1 and D-2 dopamine receptor agonists: benzimidazol-2-one, benzoxazol-2-one, and the highly potent benzothiazol-2-one 7-ethylamines.
    Weinstock J; Gaitanopoulos DE; Stringer OD; Franz RG; Hieble JP; Kinter LB; Mann WA; Flaim KE; Gessner G
    J Med Chem; 1987 Jul; 30(7):1166-76. PubMed ID: 2955118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and in vitro evaluation of 4-(2-aminoethyl)-2(3H)-indolones and related compounds as peripheral prejunctional dopamine receptor agonists.
    DeMarinis RM; Gallagher G; Hall RF; Franz RG; Webster C; Huffman WF; Schwartz MS; Kaiser C; Ross ST; Wilson JW
    J Med Chem; 1986 Jun; 29(6):939-47. PubMed ID: 3712384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FPL 63012AR: a potent D1-receptor agonist.
    Smith GW; Farmer JB; Ince F; Matu K; Mitchell PD; Naya I; Springthorpe B
    Br J Pharmacol; 1990 Jun; 100(2):295-300. PubMed ID: 1974159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SK&F 89124, a potent and selective agonist at prejunctional dopamine receptors.
    Hieble JP; Sulpizio AC; Sarau HM; Flaim KE; Blumberg AL; McCafferty JP; Zeid RL
    Fundam Clin Pharmacol; 1989; 3(6):621-42. PubMed ID: 2575569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives.
    Kaiser C; Dandridge PA; Garvey E; Flaim KE; Zeid RL; Hieble JP
    J Med Chem; 1985 Dec; 28(12):1803-10. PubMed ID: 4068005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins.
    Weinstock J; Gaitanopoulos DE; Oh HJ; Pfeiffer FR; Karash CB; Venslavsky JW; Sarau HM; Flaim KE; Hieble JP; Kaiser C
    J Med Chem; 1986 Sep; 29(9):1615-27. PubMed ID: 2875183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
    Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
    J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of N-n-propyl-N-(2-arylethyl)-5-(1H-benzimidazol-2-thione)-eth ylamines and related compounds as potential dopaminergic ligands.
    Soskic V; Dukić S; Dragović D; Joksimović J
    Arzneimittelforschung; 1996 Aug; 46(8):741-6. PubMed ID: 9125270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. trans-hexahydroindolo[4,3-ab]phenanthridines ("benzergolines"), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group.
    Seiler MP; Hagenbach A; Wüthrich HJ; Markstein R
    J Med Chem; 1991 Jan; 34(1):303-7. PubMed ID: 1671417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on antiulcer drugs. V. Synthesis and antiulcer activity of aralkylbenzazoles.
    Katsura Y; Inoue Y; Tomoi M; Takasugi H
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2062-74. PubMed ID: 1358470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
    Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
    J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
    Dragović D; Soskić V; Joksimović J
    Pharmazie; 1995 Oct; 50(10):678-80. PubMed ID: 7501691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
    Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.